Immunotherapy | LocalHealthGuide

April 2, 2019 Cancer

UW Scientists prod immune cells to attack pancreatic cancer

Their findings challenge the commonly held view that pancreatic cancer does not elicit an immune system response that is robust enough for immunotherapy to be effective.

Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID

Insurers slow to cover high-cost cancer immunotherapy

Most commercial insurers are covering CAR-T immunotherapies now, but they do so on an individual basis, writing single-patient agreements each time.